Special Issue "Equine Infectious Diseases and Immunotherapy"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 9221
Interests: comparative pathology; anatomic pathology; equine; equine viral diseases; EIAV; background lesions; African green monkeys
Infectious diseases in equines, whether endemic, emerging or reemerging in a population, represent constant challenges to veterinarians and owners. These diseases may result in a burden to equine practices and hospitals, which are constantly on the lookout for newer cost-effective diagnostic tools, therapeutic approaches, prevention strategies, or efficient epidemiological surveillance. Clinical problems can be puzzling, and this Special Issue of Vaccines aims to bring together recent knowledge on viral, bacterial, rickettsial, fungal, and parasitic diseases in equines to better understand their pathogenesis, improve therapy, and implement relevant control measures. Allergies in horses are not currently fully understood, but recent advances in immunotherapy approaches are encouraging.
The objectives of this Special Issue are to bring forward the most recent advances in equine infectious diseases, immunotherapy, and pathology, including novelties in diagnostic, as well as prevention and control. Articles introducing novel perspectives on this broad topic, as well as on vaccines, allergen-specific immunotherapy, or epidemiological findings, are welcome.
Dr. Pompei Florin Bolfa
Dr. Caroline Leroux
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immune response
- emerging diseases
- wild equids